000 01401 a2200385 4500
005 20250518044017.0
264 0 _c20200601
008 202006s 0 0 eng d
022 _a1477-2566
024 7 _a10.1016/j.jcyt.2019.05.003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCiccocioppo, R
245 0 0 _aPerspectives of the International Society for Cell & Gene Therapy Gastrointestinal Scientific Committee on the Intravenous Use of Mesenchymal Stromal Cells in Inflammatory Bowel Disease (PeMeGi).
_h[electronic resource]
260 _bCytotherapy
_c08 2019
300 _a824-839 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdministration, Intravenous
650 0 4 _aAnimals
650 0 4 _aClinical Trials as Topic
650 0 4 _aColitis, Ulcerative
_xtherapy
650 0 4 _aCrohn Disease
_xtherapy
650 0 4 _aGenetic Therapy
_xmethods
650 0 4 _aHumans
650 0 4 _aInflammatory Bowel Diseases
_xtherapy
650 0 4 _aMesenchymal Stem Cell Transplantation
_xmethods
650 0 4 _aMesenchymal Stem Cells
650 0 4 _aPatient Selection
700 1 _aBaumgart, D C
700 1 _aDos Santos, C C
700 1 _aGalipeau, J
700 1 _aKlersy, C
700 1 _aOrlando, G
773 0 _tCytotherapy
_gvol. 21
_gno. 8
_gp. 824-839
856 4 0 _uhttps://doi.org/10.1016/j.jcyt.2019.05.003
_zAvailable from publisher's website
999 _c29800332
_d29800332